Literature DB >> 24531309

Randomised comparison of strut coverage between Nobori biolimus-eluting and sirolimus-eluting stents: an optical coherence tomography analysis.

Byeong-Keuk Kim1, Jinyong Ha, Gary S Mintz, Jung-Sun Kim, Dong-Ho Shin, Young-Guk Ko, Donghoon Choi, Yangsoo Jang, Myeong-Ki Hong.   

Abstract

AIMS: The aims of this study were to compare strut tissue coverage at six-month follow-up after Nobori biolimus-eluting stent (N-BES) versus sirolimus-eluting stent (SES) implantation. METHODS AND
RESULTS: A total of 120 patients with a single stenotic lesion requiring revascularisation were randomly assigned to either N-BES (n=60) or SES (n=60). Baseline optical coherence tomography (OCT) was performed post stent implantation, and follow-up OCT was scheduled at six months. Post-intervention and follow-up OCT analyses were available in 51 (85.0%) and 52 (86.7%) patients, respectively. The primary endpoint was the percentage of uncovered struts at follow-up OCT in all cross-sections with analysis of 0.2 mm longitudinal intervals. In addition, an OCT contour plot analysis was constructed to investigate the distribution patterns of uncovered struts. The percentage of uncovered struts of N-BES was significantly lower versus SES (15.9±12.2% versus 25.1±18.3%, respectively, p=0.003). N-BES showed a greater NIH thickness than SES (median [interquartile range] 52.4 μm [41.9-74.9] versus 42.1 μm [30.6-56.0], p=0.005). Contour plot analyses showed a lower incidence of a diffuse distribution pattern of uncovered struts (46.8% versus 75.0%, respectively, p=0.022).
CONCLUSIONS: This randomised OCT study showed that N-BES had a significantly lower percentage of uncovered struts, and less common diffuse distribution pattern of uncovered struts versus SES.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24531309     DOI: 10.4244/EIJV9I12A236

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  7 in total

1.  Randomized comparison of acute stent malapposition between platinum-chromium versus cobalt-chromium everolimus-eluting stents.

Authors:  Byeong-Keuk Kim; Dong-Ho Shin; Jung-Sun Kim; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Int J Cardiovasc Imaging       Date:  2014-10-28       Impact factor: 2.357

2.  Vulnerable struts with CRE8, Biomatrix and Xience stents assessed with OCT and their correlation with clinical variables at 6-month follow-up: the CREBX-OCT study.

Authors:  Cristina Giglioli; Chiara Formentini; Salvatore Mario Romano; Emanuele Cecchi; Giorgio Jacopo Baldereschi; Daniele Landi; Marco Chiostri; Francesco Prati; Niccolò Marchionni
Journal:  Int J Cardiovasc Imaging       Date:  2019-10-30       Impact factor: 2.357

3.  Differences of side branch jailing between left main-left anterior descending artery stenting and left main-left circumflex artery stenting with Nobori biolimus-eluting stent.

Authors:  Fumiaki Nakao; Takayuki Okamura; Takeshi Suetomi; Jutaro Yamada; Takeshi Nakamura; Tooru Ueda; Takamasa Oda; Masashi Kanemoto; Yasuhiro Ikeda; Takashi Fujii; Masafumi Yano
Journal:  Heart Vessels       Date:  2016-02-15       Impact factor: 2.037

4.  Impact of statin treatment on strut coverage after drug-eluting stent implantation.

Authors:  Yongsung Suh; Byeong-Keuk Kim; Dong-Ho Shin; Jung-Sun Kim; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Yonsei Med J       Date:  2015-01       Impact factor: 2.759

5.  Severe Acute Stent Malapposition After Drug-Eluting Stent Implantation: Effects on Long-Term Clinical Outcomes.

Authors:  Seung-Yul Lee; Eui Im; Sung-Jin Hong; Chul-Min Ahn; Jung-Sun Kim; Byeong-Keuk Kim; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  J Am Heart Assoc       Date:  2019-06-25       Impact factor: 5.501

6.  Impact of Coronary Plaque Characteristics on Late Stent Malapposition after Drug-Eluting Stent Implantation.

Authors:  Sung-Jin Hong; Byeong-Keuk Kim; Dong-Ho Shin; Jung-Sun Kim; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Yonsei Med J       Date:  2015-11       Impact factor: 2.759

7.  Novel sirolimus-eluting stent Prolim® with a biodegradable polymer in the all-comers population: one year clinical results with quantitative coronary angiography and optical coherence tomography analysis.

Authors:  Jacek Bil; Robert J Gil; Adam Kern; Tomasz Pawłowski; Piotr Seweryniak; Zbigniew Śliwiński
Journal:  BMC Cardiovasc Disord       Date:  2015-11-14       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.